Cvs health corporation (CVS)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10Jun'10Mar'10Dec'09Sep'09Jun'09Mar'09
Cash flows from operating activities:
Cash receipts from customers

63,751

63,874

63,711

61,935

58,873

54,244

44,298

44,608

43,369

43,539

44,712

44,430

43,913

43,765

44,221

42,842

41,482

40,630

37,310

36,444

34,570

36,590

32,884

32,427

30,505

29,585

28,962

28,428

28,018

28,742

26,819

28,437

29,207

24,813

24,925

24,979

22,971

25,979

22,779

22,827

22,918

24,780

23,291

23,313

22,184

Cash paid for inventory and prescriptions dispensed by retail network pharmacies

36,969

39,697

39,391

34,922

35,645

41,061

37,157

105,865

-35,102

35,681

37,040

37,570

36,178

-

35,520

35,276

35,575

32,968

31,401

29,853

28,276

28,295

26,799

26,302

23,966

23,352

23,169

22,387

22,270

22,568

22,175

22,774

22,515

19,523

18,318

19,862

17,445

20,190

17,567

17,805

17,581

18,983

18,888

18,521

17,144

Insurance benefits paid

14,303

13,430

12,820

13,041

12,951

4,497

663

2,830

-1,093

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid for inventory and prescriptions dispensed by retail network pharmacies

36,969

39,697

39,391

34,922

35,645

41,061

37,157

105,865

-35,102

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Insurance benefits paid

14,303

13,430

12,820

13,041

12,951

4,497

663

2,830

-1,093

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid to other suppliers and employees

8,187

7,521

6,914

7,094

7,403

4,929

3,834

4,200

4,271

4,118

4,230

3,177

3,823

4,458

4,001

4,085

2,934

2,795

3,305

3,773

4,162

4,077

3,480

3,591

4,196

3,535

3,308

3,563

3,889

3,523

2,986

3,383

3,751

3,543

3,943

2,807

3,342

3,432

3,217

3,213

3,916

3,311

2,907

3,044

3,859

Interest received

206

199

244

262

250

238

212

144

50

6

5

4

6

6

5

4

5

6

6

6

3

4

5

3

3

3

3

1

1

2

1

0

1

1

1

1

1

1

1

1

1

1

1

1

2

Interest paid

1,128

279

1,173

379

1,123

1,044

1,199

15

545

203

330

211

328

186

339

237

378

206

112

224

87

189

127

227

104

165

102

163

104

170

130

153

128

193

156

148

150

144

155

129

155

132

126

161

123

Income taxes paid

65

512

729

1,423

53

472

560

1,404

-53

869

506

1,477

57

866

432

1,601

161

969

678

1,563

64

610

838

1,413

70

998

683

1,414

116

752

606

896

28

734

547

956

169

439

549

1,029

207

550

464

1,036

289

Net cash provided by operating activities

3,305

2,634

2,928

5,338

1,948

2,479

1,097

2,934

2,355

-136

2,611

1,999

3,533

2,121

3,934

1,647

2,439

3,698

1,820

1,037

1,984

3,423

1,645

897

2,172

1,538

1,703

902

1,640

1,731

923

1,231

2,786

821

1,962

1,207

1,866

1,775

1,292

652

1,060

1,805

907

552

771

Cash flows from investing activities:
Proceeds from sales and maturities of investments

1,288

1,433

1,830

1,800

1,986

774

6

27

10

40

5

8

8

15

9

17

50

128

75

24

16

42

16

48

55

136

0

0

0

-

-

-

-

-

-

-

-

0

0

0

1

-

-

-

-

Purchases of investments

1,535

1,523

1,949

2,015

2,047

595

44

20

33

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of property and equipment

742

567

601

573

716

585

540

430

482

506

524

431

457

617

505

504

598

877

548

523

419

700

545

503

388

654

526

486

318

716

496

442

376

704

458

401

309

626

513

465

401

796

661

625

466

Proceeds from sale-leaseback transactions

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

377

0

9

25

187

323

0

5

444

156

0

0

-

-

-

-

581

0

0

11

-

-

-

-

814

245

497

6

Acquisitions (net of cash acquired)

613

83

111

126

124

41,610

60

203

353

720

186

182

93

191

165

117

51

1,972

9,391

51

61

47

144

54

2,194

61

54

46

254

75

29

200

74

35

40

1,355

11

19

133

16

9

58

17

39

-13

Proceeds from sale of subsidiary and other assets

-

-

-

-

-

107

0

0

725

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

7

-

-

-

-

-

14

-2

12

-

1

4

2

Purchase of available-for-sale investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

3

36

83

60

11

113

-4

0

118

43

119

107

0

0

-

-

-

-

0

1

0

2

-

-

-

-

-

-

-

-

Other

-5

-26

-2

-4

-10

-10

-4

-9

2

-53

7

8

5

-59

11

9

2

7

14

6

8

3

1

2

5

41

2

6

5

23

0

0

0

-

-

-

12

-

-

-

-

-

-

-

-

Net cash used in investing activities

-1,597

-709

-829

-910

-891

-41,899

-634

-621

-131

-1,310

-433

-597

-537

-818

-421

-598

-633

-2,420

-9,910

-546

-544

-511

-349

-625

-2,560

-213

-529

-526

-567

-666

-98

-642

-443

153

-497

-1,767

-299

-252

-508

-483

-397

-24

-437

-163

-445

Cash flows from financing activities:
Net borrowings of short-term debt

255

-1,070

625

-2,560

2,285

720

0

0

-1,276

1,166

-990

-668

-106

-

-

-

-

0

-1,488

988

-185

-90

775

0

0

-814

814

-300

-390

-135

625

200

-750

-

-

-

-

-1,084

-468

1,337

200

-785

-228

-90

-1,626

Proceeds from issuance of long-term debt

3,946

278

3,458

0

0

4,967

0

0

39,376

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

1,800

1

999

Repayments of long-term debt

1,008

-14

6,451

1,017

882

3,256

2,265

0

1

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,662

2

2

52

973

847

1

301

1

351

1,750

1

-

-

-

-

Purchase of noncontrolling interest in subsidiary

-

-

-

-

-

-

-

-

-

-

-

-

-

-78

0

0

39

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments for (Proceeds from) Derivative Instrument, Financing Activities

-

-

-

-

-

0

0

-892

446

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repurchase of common stock

-

-

-

-

-

-

-

-

-

0

400

340

3,621

461

40

1,894

2,066

1,130

937

927

2,007

1,200

800

1,200

801

1,704

1,524

355

393

329

2,003

1,188

810

448

1,582

504

467

0

0

613

887

-

-

-

-

Dividends paid

652

651

646

657

649

510

510

510

508

510

511

512

516

456

455

459

470

391

391

395

399

317

324

322

325

268

276

276

277

202

207

209

211

166

167

170

171

119

119

119

122

108

110

111

110

Proceeds from exercise of stock options

154

27

72

10

101

28

84

23

107

15

125

68

121

19

84

89

104

85

66

85

126

43

112

112

154

69

122

159

150

159

159

240

278

90

77

157

107

114

26

48

97

14

145

36

55

Payments for taxes related to net share settlement of equity awards

16

27

5

36

44

58

2

33

4

1

10

49

11

0

143

-59

-12

-69

35

38

59

17

24

28

37

14

14

21

13

7

13

8

0

-

-

-

-

15

0

2

11

-7

21

4

1

Other

-4

-11

4

2

5

1

0

0

0

-

-

-

-

1

-2

0

-4

-1

-2

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

2,675

-1,440

-2,968

-4,258

816

1,892

-2,693

-520

38,140

670

-1,786

-1,502

-4,133

-121

-2,451

-1,702

-2,487

-1,697

9,743

-761

-2,406

-1,561

-1,775

-1,423

-935

1,261

-850

-751

-897

-923

-1,415

-977

-1,545

-1,268

-1,986

626

-832

-1,075

-912

-109

-702

-1,825

-565

-161

-681

Effect of exchange rate changes on cash, cash equivalents and restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

1

1

-12

-7

-4

3

-2

-1

-3

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net increase in cash, cash equivalents and restricted cash

4,383

485

-869

170

1,873

-37,532

-2,230

1,793

40,364

-775

392

-100

-1,137

1,182

1,062

-652

-680

-431

1,646

-274

-963

1,349

-480

-1,154

-1,323

2,584

331

-377

176

142

-590

-388

798

-294

-521

66

735

448

-128

60

-39

-44

-95

228

-355

Reconciliation of net income to net cash provided by operating activities:
Reconciliation of net income (loss) to net cash provided by operating activities:
Net income

2,012

1,744

1,529

1,931

1,427

-421

1,390

-2,563

998

3,287

1,285

1,098

953

1,707

1,541

924

1,147

1,499

1,247

1,272

1,221

1,321

948

1,246

1,129

1,265

1,249

1,124

954

1,116

1,006

965

775

1,064

867

815

712

1,025

808

821

770

1,050

1,021

887

738

Adjustments required to reconcile net income to net cash provided by operating activities:
Adjustments required to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization

1,086

1,096

1,092

1,072

1,111

807

620

647

644

622

615

623

619

628

611

619

617

582

532

488

490

489

477

488

477

458

461

449

502

456

443

431

423

396

407

391

374

373

370

368

358

352

301

382

354

Stock-based compensation

96

98

129

112

114

108

62

55

55

61

65

53

55

56

59

50

57

55

87

44

44

44

44

42

35

40

35

32

34

35

33

28

36

35

35

29

36

38

37

38

37

52

38

53

22

Deferred income taxes and other noncash items

-35

-

4

-195

153

-

-42

190

62

-

250

7

14

-

44

58

17

-

-190

37

-31

6

-108

28

16

-215

47

16

66

-198

4

62

21

10

5

59

70

-13

63

-22

2

-21

8

27

34

Change in operating assets and liabilities, net of effects from acquisitions:
Accounts receivable, net

2,715

-154

1,631

-1,308

1,989

-586

666

1,916

-857

661

166

162

-48

-1,471

435

148

1,131

-936

1,319

730

481

-1,135

1,288

445

139

692

943

462

113

91

283

-57

70

269

7

49

423

-186

10

-48

-308

-235

185

162

-26

Inventories

-541

1,488

526

62

-1,001

1,625

-103

-833

464

1,134

-128

-36

-456

405

170

256

-89

248

428

152

313

321

214

171

64

-91

271

-6

-186

267

59

-249

776

-270

268

-70

-514

110

196

114

-68

367

577

348

-93

Other current assets

-

-

-

-

-

-

-

-

-

-

181

-43

74

10

-172

276

-106

236

-460

138

-269

223

86

144

-70

71

-11

73

-238

422

-171

32

-286

247

9

134

30

-37

10

-8

39

-60

-19

-34

65

Other assets

1,119

240

60

-75

389

0

-171

231

-57

323

-23

37

1

-

33

1

52

-15

-35

-4

52

-28

-4

-16

39

10

-13

3

135

-43

-39

-8

189

-3

-10

10

52

-

-

-

-

-5

4

-21

24

Accounts payable and pharmacy claims and discounts payable

1,928

1,220

1,413

939

-22

490

794

1,223

-178

1,380

150

719

-539

619

406

366

798

796

655

627

756

520

701

182

339

327

599

328

-230

228

264

-389

1,044

412

-6

187

535

72

174

-171

-115

-236

292

63

-115

Health care costs payable and other insurance liabilities

139

-215

39

-57

553

-311

-224

-12

236

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued expenses

-

-

-

-

-

-

-

-

-

-

325

-503

1,848

-

1,594

-213

768

369

764

-394

153

384

643

-329

362

395

477

-515

114

441

-770

-155

1,250

-875

926

-102

156

391

50

-282

-335

728

-50

-474

-270

Other liabilities

1,372

617

655

215

-11

487

-1,197

-113

988

-404

-70

-13

154

103

44

-18

23

12

-23

-21

-72

40

3

-16

-14

-50

25

0

24

42

75

7

-14

75

2

-49

-26

-3

-9

-38

6

-53

44

69

-22